99 related articles for article (PubMed ID: 4178461)
1. Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions.
Benhamou-Glynn N; el-Kabir DJ; Doniach D; Roitt IM
Proc R Soc Med; 1968 Dec; 61(12):1303-5. PubMed ID: 4178461
[No Abstract] [Full Text] [Related]
2. Inhibition of the long-acting thyroid stimulator (LATS) by soluble thyroid fractions.
Beall G; Doniach D; Roitt I; el Kabir D
J Lab Clin Med; 1969 Jun; 73(6):988-99. PubMed ID: 4977698
[No Abstract] [Full Text] [Related]
3. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
[No Abstract] [Full Text] [Related]
4. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
[No Abstract] [Full Text] [Related]
5. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
Berumen FO; Lobsenz IL; Utiger RD
J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
[No Abstract] [Full Text] [Related]
6. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
Benhamou-Glynn N
Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
[No Abstract] [Full Text] [Related]
7. The interaction between thyroid tissue and the long-acting thyroid stimulator.
Kendall-Taylor P; Smith BR; Munro DS
Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
[No Abstract] [Full Text] [Related]
8. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
9. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
10. A comparison of the actions of thyroid-stimulating hormone and the long-acting thyroid stimulator in an in vitro assay.
Brown J; Ensor J; Munro DS
Proc R Soc Med; 1968 Jul; 61(7):652-4. PubMed ID: 5664277
[No Abstract] [Full Text] [Related]
11. In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.
Field JB; Remer A; Bloom G; Kriss JP
J Clin Invest; 1968 Jul; 47(7):1553-60. PubMed ID: 5658587
[TBL] [Abstract][Full Text] [Related]
12. LATS and thyroid autoantibodies.
Beall GN; Solomon DH
Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
[TBL] [Abstract][Full Text] [Related]
13. Experimental production of a thyroid-stimulating antithyroid antibody.
McKenzie JM
J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
[No Abstract] [Full Text] [Related]
14. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
Amino N; Miyai K; Azukizawa M; Kumahara Y
Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
[No Abstract] [Full Text] [Related]
15. REDUCTION OF GAMMA GLOBULIN WITH LONG-ACTING THYROID-STIMULATING ACTIVITY.
DORRINGTON KJ; MUNRO DS; CARNEIRO L
Lancet; 1964 Oct; 2(7365):889-91. PubMed ID: 14197190
[No Abstract] [Full Text] [Related]
16. LATS inhibition by a soluble lipoprotein from human thyroid gland.
Chopra IJ; Beall GN; Solomon DH
J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
[No Abstract] [Full Text] [Related]
17. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
[No Abstract] [Full Text] [Related]
18. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
[No Abstract] [Full Text] [Related]
19. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Knight A; Adams DD
Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
